Allianz SE grew its stake in Colgate-Palmolive Company (NYSE:CL – Free Report) by 9.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 105,200 shares of the company’s stock after acquiring an additional 9,375 shares during the period. Allianz SE’s holdings in Colgate-Palmolive were worth $8,976,000 as of its most recent filing with the SEC.
Several other large investors have also recently made changes to their positions in CL. Coastwise Capital Group LLC lifted its stake in Colgate-Palmolive by 5.2% during the 3rd quarter. Coastwise Capital Group LLC now owns 2,940 shares of the company’s stock worth $251,000 after acquiring an additional 144 shares in the last quarter. Rathbones Group PLC increased its stake in Colgate-Palmolive by 3.7% during the third quarter. Rathbones Group PLC now owns 296,435 shares of the company’s stock worth $25,292,000 after purchasing an additional 10,599 shares during the period. Sumitomo Life Insurance Co. increased its stake in Colgate-Palmolive by 1.2% during the third quarter. Sumitomo Life Insurance Co. now owns 14,570 shares of the company’s stock worth $1,243,000 after purchasing an additional 176 shares during the period. Mayflower Financial Advisors LLC lifted its position in shares of Colgate-Palmolive by 2.9% during the third quarter. Mayflower Financial Advisors LLC now owns 7,784 shares of the company’s stock worth $664,000 after purchasing an additional 217 shares in the last quarter. Finally, Advisors Asset Management Inc. acquired a new stake in shares of Colgate-Palmolive during the third quarter worth about $2,912,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have issued reports on CL. Weiss Ratings lowered shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Jefferies Financial Group reissued a “hold” rating and issued a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. TD Cowen boosted their price target on shares of Colgate-Palmolive from $90.00 to $97.00 and gave the stock a “hold” rating in a research note on Monday, November 2nd. Piper Sandler cut their price objective on Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a research report on Monday, September 21st. Finally, BNP Paribas Exane reaffirmed an “outperform” rating and set a $108.00 price objective (up from $97.00) on shares of Colgate-Palmolive in a research report on Monday, November 2nd. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $101.22.
Insider Activity at Colgate-Palmolive
In related news, CEO Noel R. Wallace sold 20,000 shares of the stock in a transaction on Thursday, November 5th. The shares were sold at an average price of $100.26, for a total value of $2,005,200.00. Following the transaction, the chief executive officer directly owned 359,700 shares of the company’s stock, valued at $36,063,522. This trade represents a 5.27% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Panagiotis Tsourapas sold 19,938 shares of Colgate-Palmolive stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the sale, the chief operating officer owned 9,111 shares in the company, valued at $899,620.14. This represents a 68.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 77,414 shares of company stock worth $7,613,786 over the last 90 days. 0.43% of the stock is owned by corporate insiders.
Colgate-Palmolive Trading Up 1.8%
CL opened at $98.65 on Friday. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.63 and a current ratio of 0.96. Colgate-Palmolive Company has a one year low of $75.96 and a one year high of $101.81. The company has a market cap of $78.42 billion, a P/E ratio of 38.69, a PEG ratio of 4.47 and a beta of 0.31. The business’s 50-day simple moving average is $92.04 and its 200-day simple moving average is $90.53.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 earnings per share. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.92 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th were issued a dividend of $0.53 per share. The ex-dividend date of this dividend was Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.1%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 83.14%.
Colgate-Palmolive Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Read More
- Five stocks we like better than Colgate-Palmolive
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
